PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 232 filers reported holding PDL BIOPHARMA INC in Q3 2014. The put-call ratio across all filers is 1.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $8,000 | 0.0% | 2,244 | -4.3% | 0.01% | +25.0% |
| Q1 2016 | $8,000 | -52.9% | 2,344 | -28.7% | 0.00% | -78.9% |
| Q3 2015 | $17,000 | -100.0% | 3,286 | -73.8% | 0.02% | -68.9% |
| Q2 2014 | $121,522,000 | +13.8% | 12,554 | -2.3% | 0.06% | +24.5% |
| Q1 2014 | $106,775,000 | +71561.1% | 12,849 | -27.7% | 0.05% | -40.2% |
| Q4 2013 | $149,000 | – | 17,762 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |